| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.07. | Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations | ||
| 01.07. | Plus Therapeutics rebrands as Cerenome as it deepens AI strategy | ||
| 01.07. | Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next? | ||
| 30.06. | AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas | ||
| 30.06. | Rising Stars: How Novo Nordisk's Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer | ||
| 30.06. | Medical journal retracts Tavneos pivotal study article, complicating Amgen's defense effort | ||
| 30.06. | After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL | ||
| 30.06. | FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program | ||
| 30.06. | Unicycive turned away by FDA again over manufacturer's plant shortfalls | ||
| 29.06. | Zymeworks acquires struggling Theravance for $929M | ||
| 29.06. | FDA rejects Sobi's gout drug over manufacturing issues, sparing Amgen blockbuster | ||
| 29.06. | Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa | ||
| 26.06. | FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483 | ||
| 26.06. | Sanofi under antitrust probe as European Commission kicks off formal proceedings | ||
| 26.06. | Pharma's Cannes-do attitude sees industry return to triumph | ||
| 26.06. | Europe's CHMP reverses endorsement of Amgen's Tavneos as FDA hearing looms | ||
| 26.06. | Eli Lilly taps AI to bring personal memories to life during its European radio show road trip | ||
| 26.06. | Fierce Pharma Asia-Historic solid tumor CAR-T nod; Inside Pfizer, Innovent's $10B pact; More China deals | ||
| 26.06. | Biogen launches 'Ready for More' HD Spinraza campaign with a focus on how we see SMA | ||
| 26.06. | BeOne boosts support for Blood Cancer United with $5M commitment | ||
| 25.06. | Bayer scores landmark victory as Supreme Court overturns Roundup verdict | ||
| 25.06. | FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos | ||
| 25.06. | Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy | ||
| 25.06. | Novartis teams up with Becoming rentABLE for its new SMA campaign | ||
| 25.06. | Ionis scores transformational FDA label expansion for Tryngolza |